Results 221 to 230 of about 693,895 (386)

Molecular attributes underlying central nervous system and systemic relapse in diffuse large B-cell lymphoma

open access: yesHaematologica, 2020
Keren Isaev   +18 more
doaj   +1 more source

From Biopsy to Diagnosis: Navigating Aggressive B-Cell Lymphomas in Practice. [PDF]

open access: yesMedicina (Kaunas)
Halcu G   +5 more
europepmc   +1 more source

Tertiary lymphoid structures in cancer – considerations for patient prognosis

open access: yesCellular & Molecular Immunology, 2020
L. Munoz-Erazo   +3 more
semanticscholar   +1 more source

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study

open access: yesAnnals of Neurology, EarlyView.
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro   +16 more
wiley   +1 more source

Maintenance rituximab following induction R-CHOP chemotherapy in patients with composite or discordant, indolent and aggressive, B-cell non-Hodgkin lymphomas

open access: yesHaematologica, 2016
Roopesh Kansara   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy